Your browser doesn't support javascript.
loading
Predicting response to immune checkpoint blockade in NSCLC with tumour-only RNA-seq.
Markham, John F; Fellowes, Andrew P; Green, Thomas; Leal, Jose Luis; Legaie, Roxane; Cullerne, Darren; Morris, Tessa; John, Tom; Solomon, Ben; Fox, Stephen B.
Afiliación
  • Markham JF; Peter MacCallum Cancer Centre, 305 Grattan Street, Parkville, VIC, 3000, Australia.
  • Fellowes AP; Department of Pathology, Peter MacCallum Cancer Centre, Parkville, VIC, Australia.
  • Green T; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.
  • Leal JL; Peter MacCallum Cancer Centre, 305 Grattan Street, Parkville, VIC, 3000, Australia. andrew.fellowes@petermac.org.
  • Legaie R; Department of Pathology, Peter MacCallum Cancer Centre, Parkville, VIC, Australia. andrew.fellowes@petermac.org.
  • Cullerne D; Peter MacCallum Cancer Centre, 305 Grattan Street, Parkville, VIC, 3000, Australia.
  • Morris T; Department of Pathology, Peter MacCallum Cancer Centre, Parkville, VIC, Australia.
  • John T; Peter MacCallum Cancer Centre, 305 Grattan Street, Parkville, VIC, 3000, Australia.
  • Solomon B; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.
  • Fox SB; Peter MacCallum Cancer Centre, 305 Grattan Street, Parkville, VIC, 3000, Australia.
Br J Cancer ; 128(6): 1148-1154, 2023 04.
Article en En | MEDLINE | ID: mdl-36572732
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Antineoplásicos Inmunológicos / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Br J Cancer Año: 2023 Tipo del documento: Article País de afiliación: Australia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Antineoplásicos Inmunológicos / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Br J Cancer Año: 2023 Tipo del documento: Article País de afiliación: Australia